LE BIOESSAI DU THROMBOXANE A2VARGAFTIG BB.1978; REV. MED.; FRA; DA. 1978; VOL. 19; NO 42; PP. 2358-2360; ABS. ENG; BIBL. 8 REF.Article

PLATELET AGGREGATION AND THROMBOXANE A₂ FORMATION IN CAT PLATELET RICH PLASMA.MARCINKIEWICZ E; GRODZINSKA L; GRYGLEWSKI RJ et al.1978; PHARMACOL. RES. COMMUNIC.; G.B.; DA. 1978; VOL. 10; NO 1; PP. 1-12; BIBL. 20 REF.Article

THROMBOXANE A₂ BIOSYNTHESIS IN HUMAN LUNG FIBROBLASTS WI-38HOPKINS NK; SUN FF; GORMAN RR et al.1978; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1978; VOL. 85; NO 2; PP. 827-836; BIBL. 28 REF.Article

METABOLIC FATE OF THROMBOXANE A₂ AND PROSTACYCLINROBERTS LJ II; BRASH AR; OATES JA et al.1982; ADV. PROSTAGLANDIN THROMBOXANE RES.; ISSN 0361-5952; USA; DA. 1982; VOL. 10; PP. 211-225; BIBL. 83 REF.Article

PLATELET AGGREGABILITY, THROMBOSCANE A₂ AND MALONALDEHYDE FORMATION FOLLOWING ADMINISTRATION OF ASPIRIN TO MANSZCZEKLIK A; GRYGLEWSKI RJ; GRODZINSKA L et al.1979; THROMBOSIS RES.; GBR; DA. 1979; VOL. 15; NO 3-4; PP. 405-413; BIBL. 23 REF.Article

THROMBOXANE MOLECULES DO NOT ADOPT THE PROSTAGLANDIN HAIRPIN CONFORMATIONLANGS DA; FORTIER S; ERMAN MG et al.1979; NATURE; GBR; DA. 1979; VOL. 281; NO 5728; PP. 237-238; BIBL. 19 REF.Article

REDUCED PLATELET THROMBOXANE FORMATION IN UREMIA: EVIDENCE FOR A FUNCTIONAL CYCLOOXYGENASE DEFECTREMUZZI G; BENIGNI A; DODESINI P et al.1983; JOURNAL OF CLINICAL INVESTIGATION; ISSN 0021-9738; USA; DA. 1983; VOL. 71; NO 3; PP. 762-768; BIBL. 30 REF.Article

BIOLOGICAL SIGNIFICANCE AND THERAPEUTIC POTENTIAL OF PROSTACYCLINMONCADA S; VANE JR.1980; J. MEDICIN. CHEM.; USA; DA. 1980; VOL. 23; NO 6; PP. 591-593; BIBL. 24 REF.Article

EXPERIMENTAL ISCHEMIC HEART DISEASE: EFFECTS OF SYNTHETIC THROMBOXANE A₂MOROOKA S; KOBAYASHI M; TAKAHASHI T et al.1979; EXPER. MOLEC. PATHOL.; USA; DA. 1979; VOL. 30; NO 3; PP. 449-457; BIBL. 10 REF.Article

MECHANISMS OF BRONCHOCONSTRICTION AND OF THROMBOCYTOPENIA INDUCED BY COLLAGEN IN THE GUINEA PIGVARGAFTIG BB; LEFORT J; JOSEPH D et al.1979; EUROP. J. PHARMACOL.; NLD; DA. 1979; VOL. 58; NO 3; PP. 273-284; BIBL. 2 P.Article

PHARMACOLOGY AND ENDOGENOUS ROLES OF PROSTAGLANDIN ENDOPEROXIDES, THROMBOXANE A₂, AND PROSTACYCLINMONCADA S; VANE JR.1978; PHARMACOL. REV.; USA; DA. 1978 PUBL. 1979; VOL. 30; NO 3; PP. 293-331; BIBL. 399 REF.Article

FACTEURS THROMBOGENES ET ATHEROME.RABY C.1978; ANGEIOLOGIE; FR.; DA. 1978; VOL. 30; NO SPEC.; PP. 16-19; ABS. ANGL.Article

GENERATION OF TXA₂ IN GUINEA PIG LUNGS: THE ROLE OF HISTAMINE RECEPTORSFOLCO GC; OMINI C; VIGANO T et al.1979; ADV. INFLAMM. RES.; USA; DA. 1979; VOL. 1; PP. 477-484; BIBL. 17 REF.Conference Paper

HEART ATTACK INDUCED EXPERIMENTALLY WITH THROMBOXANE A₂.SHIMAMOTO T; KOBAYASHI M; TAKAHASHI T et al.1977; PROC. JAP. ACAD., B; JAP.; DA. 1977; VOL. 53; NO 1; PP. 38-42; BIBL. 5 REF.Article

PROSTACYCLINE AND THROMBOXANES. IMPLICATIONS FOR THEIR ROLE IN TUMOR CELL METASTASIS = PROSTACYCLINE ET THROMBOXANES. IMPLICATIONS POUR LEUR ROLE DANS LES METASTASES DES CELLULES TUMORALESHONN KV; BUSSE WD; SLOANA BF et al.1983; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1983; VOL. 32; NO 1; PP. 1-11; BIBL. 133 REF.; GRAPH, FIGArticle

EFFECTS OF PROSTAGLANDINS AND THROMBOXANE A₂ ON THE CORONARY CIRCULATION OF ADULT DOGS AND PUPPIESHSUEH HWA WANG; KULKARNI PS; EAKINS KE et al.1980; EUROP. J. PHARMACOL.; NLD; DA. 1980; VOL. 66; NO 1; PP. 31-41; BIBL. 17 REF.Article

THROMBOXANE A₂ RELEASE AND THE INJURY-SPASM HYPOTHESISHELLSTROM HR; LEWY RI.1980; CIRCULATION; ISSN 0009-7322; USA; DA. 1980; VOL. 62; NO 3; PP. 667-668; BIBL. 19 REF.Article

UNMASKING OF THROMBOXANE A₂ SYNTHESIS BY URETERAL OBSTRUCTION IN THE RABBIT KIDNEY.MORRISON AR; NISHIKAWA K; NEEDLEMAN P et al.1977; NATURE; G.B.; DA. 1977; VOL. 267; NO 5608; PP. 259-260; BIBL. 14 REF.Article

N-0164 INHIBITS GENERATION OF THROMBOXANE-A₂-LIKE ACTIVITY FROM PROSTAGLANDIN ENDOPEROXIDES BY HUMAN PLATELET MICROSOMES.KULKARNI PS; EAKINS KE.1976; PROSTAGLANDINS; U.S.A.; DA. 1976; VOL. 12; NO 3; PP. 465-469; BIBL. 1 P.Article

BIOLOGICAL EFFECTS OF 15-HYDROPEROXYTHROMBOXANE A₂ ON PLATELETS AND AORTAHAMMARSTROEM S.1980; PROSTAGLANDINS MED.; GBR; DA. 1980; VOL. 4; NO 5; PP. 297-302; BIBL. 11 REF.Article

RENAL EFFECTS OF PINANE-THROMBOXANE A₂ AND INDOMETHACIN IN SALINE VOLUME-EXPANDED SPONTANEOUSLY HYPERTENSIVE RATSSHIBOUTA Y; TERASHITA Z; INADA Y et al.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 85; NO 1-5; PP. 51-59; BIBL. 2 P.Article

EFFECTS OF PROVOCATION ON TRANSCARDIAC THROMBOXANE IN PATIENTS WITH CORONARY ARTERY DISEASEHIRSH PD; FIRTH BG; CAMPBELL WB et al.1983; AMERICAN (THE) JOURNAL OF CARDIOLOGY; ISSN 0002-9149; USA; DA. 1983; VOL. 51; NO 5; PP. 727-733; BIBL. 39 REF.Article

PROSTACYCLIN IN PHYSIOLOGY AND PATHOPHYSIOLOGYVANE JR; BUNTING S; MONCADA S et al.1982; INT. REV. EXP. PATHOL.; ISSN 0074-7718; USA; DA. 1982; VOL. 23; PP. 161-207; BIBL. 12 P.Article

CARBOCYCLIC THROMBOXANE A₂: AGGREVATION OF MYOCARDIAL ISCHEMIA BY A NEW SYNTHETIC THROMBOXANE A₂ ANALOGSMITH EF III; LEFER AM; AHARONY D et al.1981; PROSTAGLANDINS; ISSN 0090-6980; USA; DA. 1981; VOL. 21; NO 3; PP. 443-456; BIBL. 3 P.Article

ENZYMATIC SYNTHESIS OF 15-HYDROPEROXYTHROMBOXANE A₂ AND 12-HYDROPEROXY-5,8,10-HEPTADECATRIENOIC ACIDHAMMARSTROM S.1980; J. BIOL. CHEM.; USA; DA. 1980; VOL. 255; NO 2; PP. 518-521; BIBL. 18 REF.Article